Edward Tobinick MD Blog

Comments: 0

Rapid improvement in speech, etc., after treatment by Edward Tobinick, M.D., on 12/31/19

Patient from California after perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, December 31, 2019.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Monday, January 6, 2020 at 4:58 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Aphasia, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Stroke Breakthrough – Multiple improvements after treatment by Edward Tobinick, M.D., on 12/26/19

Patient from Cali, Columbia able to salsa within minutes after perispinal etanercept treatment by Dr. Tobinick. Multiple additional neurological improvements occurred, including reductions in chronic post-stroke pain and neglect; and improvements in hand and arm control, balance, and agility and reduced right eyelid droop (ptosis). Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, December 26, 2019.

Posted by INR PLLC on Monday, January 6, 2020 at 1:18 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Aphasia, central post-stroke pain, CPSP, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Post Stroke Pain, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Able to walk unassisted after treatment by Edward Tobinick, M.D. on 12/4/19

Family from Columbia. Able to walk unassisted immediately after treatment with perispinal etanercept by Dr. Tobinick. Filmed at the Institute of Neurological Recovery in Boca Raton, Florida, December 4, 2019.

Posted by INR PLLC on Monday, December 9, 2019 at 6:07 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick, v

Comments: 0

Immediate neurological improvement after treatment by Edward Tobinick, M.D., two years after cardiac arrest

Perispinal etanercept treatment by Dr. Tobinick at the Institute of Neurological Recovery in Boca Raton, Florida, November 15, 2019.

Posted by INR PLLC on Wednesday, November 27, 2019 at 1:49 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #cardiac arrest, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Rapid improvements 3 years post-stroke after treatment by Edward Tobinick, M.D.

Perispinal etanercept treatment by Dr. Tobinick at the INR in Boca Raton, Florida, on October 25, 2019.

Posted by INR PLLC on Thursday, November 7, 2019 at 10:27 am
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with Anti-Inflammatory, Edward Tobinick, Inflammation, INR PLLC, Institute of Neurological Recovery, Perispinal Etanercept, Sensation, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

About Dr. Tobinick

Edward Lewis Tobinick is an American physician who is the inventor of the perispinal etanercept treatment for chronic stroke pain whose efficacy has been established by a randomized, double-blind, placebo-controlled clinical trial published in January 2020.

Dr. Tobinick graduated Phi Beta Kappa and Magna Cum Laude with honors in biology from Brandeis University in Waltham, Massachusetts and received his M.D. from the University of California San Diego School of Medicine in La Jolla, California.

The published scientific articles documenting unprecedented neurological effects produced by the novel method of drug delivery invented by Dr. Tobinick have been cited by hundreds of scientists from academic centers around the world.

Dr. Tobinick's breakthrough stroke treatment has been used to treat patients from every continent in the world, including from the U.S., Canada, England, Scotland, Wales, Ireland, Mexico, Trinidad, Jamaica, Haiti, Bahamas, Guatemala, Belize, Brazil, Columbia, Bolivia, Uruguay, Ecuador, Chile, Peru, Germany, France, Spain, Italy, Portugal, Belgium, Netherlands, Switzerland, Bulgaria, Romania, Ukraine, Poland, Denmark, Sweden, Norway, Iceland, Gibraltar, Uzbekistan, Turkey, Israel, Saudi Arabia, UAE, Oman, Iraq, Egypt, Morocco, Nigeria, Ghana, Cameroon, South Africa, Mozambique, Kenya, Mauritius, India, Bangladesh, Thailand, Vietnam, China, Hong Kong, Japan, Indonesia, Malaysia, Philippines, Australia, New Zealand, Papua New Guinea, Fiji, and the Cook Islands.

In 2018 the Australian Minister of Health, Hon. Greg Hunt, designated substantial funds to study Dr. Tobinick's breakthrough stroke treatment in Australia.

Dr. Tobinick has been an invited ad hoc reviewer for the journals Brain Research, Clinical Drug Investigation, CNS Drugs, Current Alzheimer Research, Experimental Neurology, Future Neurology, Journal of Neurochemistry, Journal of Neuroimmunology, Neuroscience, and Pharmaceutical Medicine and a member of the Editorial Board of the Journal of Neuroinflammation.

More Info